Which has better earnings & valuation, CLBT or IREN?

IREN has higher revenue and earnings than Cellebrite DI. Cellebrite DI is trading at a lower price-to-earnings ratio than IREN, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cellebrite DI $475.67M 5.84 $78.33M $0.22 50.64 IREN $501.02M 31.43 $86.94M $0.48 91.79

Is CLBT or IREN more profitable?

IREN has a net margin of 20.90% compared to Cellebrite DI's net margin of 11.43%. Cellebrite DI's return on equity of 15.58% beat IREN's return on equity. Company Net Margins Return on Equity Return on Assets Cellebrite DI 11.43% 15.58% 8.29% IREN 20.90% -13.13% -6.03%

Does the media prefer CLBT or IREN?

In the previous week, Cellebrite DI had 6 more articles in the media than IREN. MarketBeat recorded 40 mentions for Cellebrite DI and 34 mentions for IREN. IREN's average media sentiment score of 0.59 beat Cellebrite DI's score of 0.14 indicating that IREN is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cellebrite DI 7 Very Positive mention(s) 6 Positive mention(s) 9 Neutral mention(s) 5 Negative mention(s) 1 Very Negative mention(s) Neutral IREN 10 Very Positive mention(s) 10 Positive mention(s) 7 Neutral mention(s) 6 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor GWRE or CLBT?

In the previous week, Cellebrite DI had 25 more articles in the media than Guidewire Software. MarketBeat recorded 40 mentions for Cellebrite DI and 15 mentions for Guidewire Software. Guidewire Software's average media sentiment score of 0.76 beat Cellebrite DI's score of 0.14 indicating that Guidewire Software is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guidewire Software 6 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Cellebrite DI 7 Very Positive mention(s) 6 Positive mention(s) 9 Neutral mention(s) 5 Negative mention(s) 1 Very Negative mention(s) Neutral

Which has better valuation & earnings, DT or CLBT?

Dynatrace has higher revenue and earnings than Cellebrite DI. Cellebrite DI is trading at a lower price-to-earnings ratio than Dynatrace, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Dynatrace $2.02B 7.02 $162.67M $0.50 98.06 Cellebrite DI $475.67M 5.84 $78.33M $0.22 50.64

Does the media refer more to DT or CLBT?

In the previous week, Cellebrite DI had 20 more articles in the media than Dynatrace. MarketBeat recorded 40 mentions for Cellebrite DI and 20 mentions for Dynatrace. Dynatrace's average media sentiment score of 0.52 beat Cellebrite DI's score of 0.14 indicating that Dynatrace is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Dynatrace 6 Very Positive mention(s) 2 Positive mention(s) 10 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cellebrite DI 7 Very Positive mention(s) 6 Positive mention(s) 9 Neutral mention(s) 5 Negative mention(s) 1 Very Negative mention(s) Neutral

Does the media refer more to AUR or CLBT?

In the previous week, Cellebrite DI had 25 more articles in the media than Aurora Innovation. MarketBeat recorded 40 mentions for Cellebrite DI and 15 mentions for Aurora Innovation. Aurora Innovation's average media sentiment score of 0.49 beat Cellebrite DI's score of 0.14 indicating that Aurora Innovation is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aurora Innovation 8 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Cellebrite DI 7 Very Positive mention(s) 6 Positive mention(s) 9 Neutral mention(s) 5 Negative mention(s) 1 Very Negative mention(s) Neutral

Which has preferable earnings & valuation, CLBT or TRMB?

Trimble has higher revenue and earnings than Cellebrite DI. Trimble is trading at a lower price-to-earnings ratio than Cellebrite DI, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cellebrite DI $475.67M 5.84 $78.33M $0.22 50.64 Trimble $3.59B 3.74 $424M -$0.49 N/A

Is CLBT or TRMB more profitable?

Cellebrite DI has a net margin of 11.43% compared to Trimble's net margin of -2.77%. Cellebrite DI's return on equity of 15.58% beat Trimble's return on equity. Company Net Margins Return on Equity Return on Assets Cellebrite DI 11.43% 15.58% 8.29% Trimble -2.77% 12.29% 7.67%

Does the media refer more to CLBT or TRMB?

In the previous week, Cellebrite DI had 12 more articles in the media than Trimble. MarketBeat recorded 40 mentions for Cellebrite DI and 28 mentions for Trimble. Trimble's average media sentiment score of 0.56 beat Cellebrite DI's score of 0.14 indicating that Trimble is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cellebrite DI 7 Very Positive mention(s) 6 Positive mention(s) 9 Neutral mention(s) 5 Negative mention(s) 1 Very Negative mention(s) Neutral Trimble 6 Very Positive mention(s) 2 Positive mention(s) 10 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Positive

Cellebrite DI (CLBT) Competitors

$11.14 +0.34 (+3.15%)

Closing price 08/14/2026 04:00 PM Eastern

Extended Trading

$11.16 +0.02 (+0.19%)

As of 08/14/2026 07:59 PM Eastern

Compare

CLBT vs. IREN, GWRE, DT, AUR, and TRMB

Should you buy Cellebrite DI stock or one of its competitors? Cellebrite DI's main competitors and comparable companies include IREN (IREN), Guidewire Software (GWRE), Dynatrace (DT), Aurora Innovation (AUR), and Trimble (TRMB). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "application software" industry.

How does Cellebrite DI compare to IREN?

Cellebrite DI (NASDAQ:CLBT) and IREN (NASDAQ:IREN) are both technology companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, dividends, earnings, valuation, profitability, risk and institutional ownership.

45.9% of Cellebrite DI shares are owned by institutional investors. Comparatively, 41.1% of IREN shares are owned by institutional investors. 5.7% of Cellebrite DI shares are owned by company insiders. Comparatively, 5.0% of IREN shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

IREN has a net margin of 20.90% compared to Cellebrite DI's net margin of 11.43%. Cellebrite DI's return on equity of 15.58% beat IREN's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cellebrite DI	11.43%	15.58%	8.29%
IREN	20.90%	-13.13%	-6.03%

IREN has higher revenue and earnings than Cellebrite DI. Cellebrite DI is trading at a lower price-to-earnings ratio than IREN, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cellebrite DI	$475.67M	5.84	$78.33M	$0.22	50.64
IREN	$501.02M	31.43	$86.94M	$0.48	91.79

Cellebrite DI presently has a consensus price target of $16.70, suggesting a potential upside of 49.91%. IREN has a consensus price target of $83.00, suggesting a potential upside of 88.38%. Given IREN's higher possible upside, analysts plainly believe IREN is more favorable than Cellebrite DI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cellebrite DI	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67
IREN	2 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.67

Cellebrite DI has a beta of 1.18, suggesting that its stock price is 18% more volatile than the broader market. Comparatively, IREN has a beta of 4.29, suggesting that its stock price is 329% more volatile than the broader market.

In the previous week, Cellebrite DI had 6 more articles in the media than IREN. MarketBeat recorded 40 mentions for Cellebrite DI and 34 mentions for IREN. IREN's average media sentiment score of 0.59 beat Cellebrite DI's score of 0.14 indicating that IREN is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cellebrite DI	7 Very Positive mention(s)	6 Positive mention(s)	9 Neutral mention(s)	5 Negative mention(s)	1 Very Negative mention(s)	Neutral
IREN	10 Very Positive mention(s)	10 Positive mention(s)	7 Neutral mention(s)	6 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

IREN beats Cellebrite DI on 11 of the 16 factors compared between the two stocks.

How does Cellebrite DI compare to Guidewire Software?

Guidewire Software (NYSE:GWRE) and Cellebrite DI (NASDAQ:CLBT) are both technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends, media sentiment and profitability.

In the previous week, Cellebrite DI had 25 more articles in the media than Guidewire Software. MarketBeat recorded 40 mentions for Cellebrite DI and 15 mentions for Guidewire Software. Guidewire Software's average media sentiment score of 0.76 beat Cellebrite DI's score of 0.14 indicating that Guidewire Software is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guidewire Software	6 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Cellebrite DI	7 Very Positive mention(s)	6 Positive mention(s)	9 Neutral mention(s)	5 Negative mention(s)	1 Very Negative mention(s)	Neutral

Guidewire Software presently has a consensus price target of $220.21, indicating a potential upside of 25.44%. Cellebrite DI has a consensus price target of $16.70, indicating a potential upside of 49.91%. Given Cellebrite DI's higher possible upside, analysts clearly believe Cellebrite DI is more favorable than Guidewire Software.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guidewire Software	0 Sell rating(s)	3 Hold rating(s)	12 Buy rating(s)	1 Strong Buy rating(s)	2.88
Cellebrite DI	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67

Cellebrite DI has lower revenue, but higher earnings than Guidewire Software. Cellebrite DI is trading at a lower price-to-earnings ratio than Guidewire Software, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guidewire Software	$1.20B	12.16	$69.80M	$1.85	94.89
Cellebrite DI	$475.67M	5.84	$78.33M	$0.22	50.64

Cellebrite DI has a net margin of 11.43% compared to Guidewire Software's net margin of 11.25%. Cellebrite DI's return on equity of 15.58% beat Guidewire Software's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guidewire Software	11.25%	12.62%	6.93%
Cellebrite DI	11.43%	15.58%	8.29%

45.9% of Cellebrite DI shares are held by institutional investors. 0.5% of Guidewire Software shares are held by insiders. Comparatively, 5.7% of Cellebrite DI shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Guidewire Software has a beta of 0.92, indicating that its share price is 8% less volatile than the broader market. Comparatively, Cellebrite DI has a beta of 1.18, indicating that its share price is 18% more volatile than the broader market.

Summary

Cellebrite DI beats Guidewire Software on 9 of the 17 factors compared between the two stocks.

How does Cellebrite DI compare to Dynatrace?

Dynatrace (NYSE:DT) and Cellebrite DI (NASDAQ:CLBT) are both technology companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, dividends, media sentiment, valuation and analyst recommendations.

In the previous week, Cellebrite DI had 20 more articles in the media than Dynatrace. MarketBeat recorded 40 mentions for Cellebrite DI and 20 mentions for Dynatrace. Dynatrace's average media sentiment score of 0.52 beat Cellebrite DI's score of 0.14 indicating that Dynatrace is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Dynatrace	6 Very Positive mention(s)	2 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cellebrite DI	7 Very Positive mention(s)	6 Positive mention(s)	9 Neutral mention(s)	5 Negative mention(s)	1 Very Negative mention(s)	Neutral

Dynatrace currently has a consensus price target of $53.96, suggesting a potential upside of 10.06%. Cellebrite DI has a consensus price target of $16.70, suggesting a potential upside of 49.91%. Given Cellebrite DI's higher probable upside, analysts clearly believe Cellebrite DI is more favorable than Dynatrace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dynatrace	0 Sell rating(s)	8 Hold rating(s)	22 Buy rating(s)	0 Strong Buy rating(s)	2.73
Cellebrite DI	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67

94.3% of Dynatrace shares are owned by institutional investors. Comparatively, 45.9% of Cellebrite DI shares are owned by institutional investors. 0.7% of Dynatrace shares are owned by company insiders. Comparatively, 5.7% of Cellebrite DI shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Dynatrace has a beta of 0.72, indicating that its stock price is 28% less volatile than the broader market. Comparatively, Cellebrite DI has a beta of 1.18, indicating that its stock price is 18% more volatile than the broader market.

Cellebrite DI has a net margin of 11.43% compared to Dynatrace's net margin of 7.22%. Cellebrite DI's return on equity of 15.58% beat Dynatrace's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dynatrace	7.22%	11.07%	7.02%
Cellebrite DI	11.43%	15.58%	8.29%

Dynatrace has higher revenue and earnings than Cellebrite DI. Cellebrite DI is trading at a lower price-to-earnings ratio than Dynatrace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dynatrace	$2.02B	7.02	$162.67M	$0.50	98.06
Cellebrite DI	$475.67M	5.84	$78.33M	$0.22	50.64

Summary

Dynatrace beats Cellebrite DI on 9 of the 16 factors compared between the two stocks.

How does Cellebrite DI compare to Aurora Innovation?

Aurora Innovation (NASDAQ:AUR) and Cellebrite DI (NASDAQ:CLBT) are both technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, institutional ownership, profitability, media sentiment, risk and dividends.

Aurora Innovation presently has a consensus price target of $12.22, indicating a potential upside of 74.85%. Cellebrite DI has a consensus price target of $16.70, indicating a potential upside of 49.91%. Given Aurora Innovation's higher probable upside, analysts clearly believe Aurora Innovation is more favorable than Cellebrite DI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurora Innovation	2 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.45
Cellebrite DI	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67

Aurora Innovation has a beta of 2.64, indicating that its share price is 164% more volatile than the broader market. Comparatively, Cellebrite DI has a beta of 1.18, indicating that its share price is 18% more volatile than the broader market.

Cellebrite DI has a net margin of 11.43% compared to Aurora Innovation's net margin of -18,000.00%. Cellebrite DI's return on equity of 15.58% beat Aurora Innovation's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aurora Innovation	-18,000.00%	-43.94%	-39.85%
Cellebrite DI	11.43%	15.58%	8.29%

Cellebrite DI has higher revenue and earnings than Aurora Innovation. Aurora Innovation is trading at a lower price-to-earnings ratio than Cellebrite DI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurora Innovation	$3M	4,669.69	-$816M	-$0.47	N/A
Cellebrite DI	$475.67M	5.84	$78.33M	$0.22	50.64

44.7% of Aurora Innovation shares are held by institutional investors. Comparatively, 45.9% of Cellebrite DI shares are held by institutional investors. 8.5% of Aurora Innovation shares are held by company insiders. Comparatively, 5.7% of Cellebrite DI shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Cellebrite DI had 25 more articles in the media than Aurora Innovation. MarketBeat recorded 40 mentions for Cellebrite DI and 15 mentions for Aurora Innovation. Aurora Innovation's average media sentiment score of 0.49 beat Cellebrite DI's score of 0.14 indicating that Aurora Innovation is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aurora Innovation	8 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cellebrite DI	7 Very Positive mention(s)	6 Positive mention(s)	9 Neutral mention(s)	5 Negative mention(s)	1 Very Negative mention(s)	Neutral

Summary

Cellebrite DI beats Aurora Innovation on 10 of the 16 factors compared between the two stocks.

How does Cellebrite DI compare to Trimble?

Cellebrite DI (NASDAQ:CLBT) and Trimble (NASDAQ:TRMB) are both technology companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, earnings, media sentiment, dividends, risk and analyst recommendations.

Trimble has higher revenue and earnings than Cellebrite DI. Trimble is trading at a lower price-to-earnings ratio than Cellebrite DI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cellebrite DI	$475.67M	5.84	$78.33M	$0.22	50.64
Trimble	$3.59B	3.74	$424M	-$0.49	N/A

Cellebrite DI has a net margin of 11.43% compared to Trimble's net margin of -2.77%. Cellebrite DI's return on equity of 15.58% beat Trimble's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cellebrite DI	11.43%	15.58%	8.29%
Trimble	-2.77%	12.29%	7.67%

45.9% of Cellebrite DI shares are held by institutional investors. Comparatively, 93.2% of Trimble shares are held by institutional investors. 5.7% of Cellebrite DI shares are held by company insiders. Comparatively, 0.6% of Trimble shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Cellebrite DI presently has a consensus price target of $16.70, suggesting a potential upside of 49.91%. Trimble has a consensus price target of $81.67, suggesting a potential upside of 41.78%. Given Cellebrite DI's higher possible upside, analysts plainly believe Cellebrite DI is more favorable than Trimble.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cellebrite DI	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67
Trimble	1 Sell rating(s)	2 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.67

In the previous week, Cellebrite DI had 12 more articles in the media than Trimble. MarketBeat recorded 40 mentions for Cellebrite DI and 28 mentions for Trimble. Trimble's average media sentiment score of 0.56 beat Cellebrite DI's score of 0.14 indicating that Trimble is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cellebrite DI	7 Very Positive mention(s)	6 Positive mention(s)	9 Neutral mention(s)	5 Negative mention(s)	1 Very Negative mention(s)	Neutral
Trimble	6 Very Positive mention(s)	2 Positive mention(s)	10 Neutral mention(s)	4 Negative mention(s)	0 Very Negative mention(s)	Positive

Cellebrite DI has a beta of 1.18, indicating that its share price is 18% more volatile than the broader market. Comparatively, Trimble has a beta of 1.37, indicating that its share price is 37% more volatile than the broader market.

Summary

Cellebrite DI beats Trimble on 9 of the 15 factors compared between the two stocks.

Get Cellebrite DI News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CLBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CLBT vs. The Competition

Export

Metric	Cellebrite DI	Software Industry	Technology Sector	NASDAQ Exchange
Market Cap	$2.78B	$15.89B	$30.69B	$13.06B
Dividend Yield	N/A	3.42%	2.73%	10.63%
P/E Ratio	50.64	123.30	71.03	21.68
Price / Sales	5.84	1,309.64	604.17	93.83
Price / Cash	27.57	45.53	53.46	38.43
Price / Book	5.51	8.74	8.38	6.52
Net Income	$78.33M	$437.23M	$682.60M	$346.94M
7 Day Performance	-30.42%	0.16%	1.45%	1.08%
1 Month Performance	-29.63%	3.17%	4.35%	1.87%
1 Year Performance	-28.59%	6.96%	200.02%	20.79%

Cellebrite DI Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CLBT Cellebrite DI	4.5533 of 5 stars	$11.14 +3.1%	$16.70 +49.9%	-28.6%	$2.78B	$475.67M	50.64	1,285	Trending News Earnings Report Analyst Downgrade Insider Trade Options Volume High Trading Volume
IREN IREN	3.1017 of 5 stars	$38.74 -6.0%	$82.71 +113.5%	+123.8%	$14.73B	$501.02M	80.71	100	Trending News Analyst Forecast
GWRE Guidewire Software	4.2051 of 5 stars	$173.33 +1.6%	$220.21 +27.0%	-17.1%	$14.20B	$1.20B	93.69	3,772
DT Dynatrace	3.3407 of 5 stars	$50.61 +3.3%	$53.77 +6.2%	+1.7%	$14.15B	$2.02B	101.22	5,600	Trending News Analyst Downgrade
AUR Aurora Innovation	2.9949 of 5 stars	$6.98 -1.1%	$12.22 +75.1%	+9.4%	$14.15B	$3M	N/A	1,900	Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CLBT) was last updated on 8/16/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cellebrite DI (CLBT) Competitors

CLBT vs. IREN, GWRE, DT, AUR, and TRMB

How does Cellebrite DI compare to IREN?

Summary

How does Cellebrite DI compare to Guidewire Software?

Summary

How does Cellebrite DI compare to Dynatrace?

Summary

How does Cellebrite DI compare to Aurora Innovation?

Summary

How does Cellebrite DI compare to Trimble?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CLBT vs. The Competition

Cellebrite DI Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cellebrite DI (CLBT) Competitors

CLBT vs. IREN, GWRE, DT, AUR, and TRMB

How does Cellebrite DI compare to IREN?

Do institutionals and insiders hold more shares of CLBT or IREN?

Is CLBT or IREN more profitable?

Which has better earnings & valuation, CLBT or IREN?

Do analysts rate CLBT or IREN?

Which has more risk and volatility, CLBT or IREN?

Does the media prefer CLBT or IREN?

Summary

How does Cellebrite DI compare to Guidewire Software?

Does the media favor GWRE or CLBT?

Do analysts recommend GWRE or CLBT?

Which has better valuation and earnings, GWRE or CLBT?

Is GWRE or CLBT more profitable?

Do insiders & institutionals hold more shares of GWRE or CLBT?

Which has more risk & volatility, GWRE or CLBT?

Summary

How does Cellebrite DI compare to Dynatrace?

Does the media refer more to DT or CLBT?

Do analysts recommend DT or CLBT?

Do institutionals and insiders have more ownership in DT or CLBT?

Which has more volatility & risk, DT or CLBT?

Is DT or CLBT more profitable?

Which has better valuation & earnings, DT or CLBT?

Summary

How does Cellebrite DI compare to Aurora Innovation?

Do analysts recommend AUR or CLBT?

Which has more volatility and risk, AUR or CLBT?

Is AUR or CLBT more profitable?

Which has preferable valuation & earnings, AUR or CLBT?

Do institutionals & insiders believe in AUR or CLBT?

Does the media refer more to AUR or CLBT?

Summary

How does Cellebrite DI compare to Trimble?

Which has preferable earnings & valuation, CLBT or TRMB?

Is CLBT or TRMB more profitable?

Do insiders & institutionals have more ownership in CLBT or TRMB?

Do analysts recommend CLBT or TRMB?

Does the media refer more to CLBT or TRMB?

Which has more volatility and risk, CLBT or TRMB?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CLBT vs. The Competition

Cellebrite DI Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools